Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk

Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk

Purpose of Review: Advances in pharmacogenomics have paved the way for personalized medicine. Cardiovascular diseases still represent the leading cause of mortality in the world. The aim of this review is to summarize the background, rationale, and evidence of pharmacogenomics in cardiovascular medi...

Full description

Bibliographic Details
Main Authors: Alfredo Mauriello, Antonia Ascrizzi, Riccardo Molinari, Luigi Falco, Alfredo Caturano, Antonello D’Andrea, Vincenzo Russo
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Genes
Subjects:
antiplatelets
anticoagulants
pharmacogenetics
adverse drug reactions
clinical implementation
Online Access:https://www.mdpi.com/2073-4425/14/11/2057

Internet

https://www.mdpi.com/2073-4425/14/11/2057

Similar Items